Home Biosimilar Antibodies Immunology & Inflammation PD-1/PD-L1 antibody Nofazinlimab (Anti-PDCD1 / PD-1 / CD279) For research use only.
Not for use in humans.

Nofazinlimab (Anti-PDCD1 / PD-1 / CD279)

Synonyms: CS1003

Nofazinlimab (anti-PDCD1/ PD-1 / CD279) is a humanised IgG4 monoclonal antibody targeting PD-1. Nofazinlimab has the potential to be used in unresectable hepatocellular carcinoma (uHCC) research. MW: 145.08 KD.

Nofazinlimab (Anti-PDCD1 / PD-1 / CD279)

Purity & Quality Control

≥99

Choose Selective PD-1/PD-L1 Inhibitors

Biological Activity

Description Nofazinlimab (anti-PDCD1/ PD-1 / CD279) is a humanised IgG4 monoclonal antibody targeting PD-1. Nofazinlimab has the potential to be used in unresectable hepatocellular carcinoma (uHCC) research. MW: 145.08 KD.

Product Details

CAS No. 2377845-98-0
Molecular Weight 145.08
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Nofazinlimab (Anti-PDCD1 / PD-1 / CD279) | Nofazinlimab (Anti-PDCD1 / PD-1 / CD279) supplier | purchase Nofazinlimab (Anti-PDCD1 / PD-1 / CD279) | Nofazinlimab (Anti-PDCD1 / PD-1 / CD279) cost | Nofazinlimab (Anti-PDCD1 / PD-1 / CD279) manufacturer | order Nofazinlimab (Anti-PDCD1 / PD-1 / CD279) | Nofazinlimab (Anti-PDCD1 / PD-1 / CD279) distributor